Meeting Banner
Abstract #2096

Chemical exchange saturation transfer imaging for neurodegenerative diseases

Yuki Matsumoto1, Masafumi Harada1, Yuki Kanazawa2, Maki Otomo1, and Mitsuharu Miyoshi3

1Department of Radiology and Radiation Oncology, Institute of Biomedical Sciences, Tokushima-shi, Japan, 2Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima-shi, Japan, 3Global MR Applications and Workflow, GE Healthcare Japan, Hino-shi, Japan

The purpose of this study is to investigate the relationship between CEST imaging and several neurodegenerative diseases to verify the feasibility of an estimation parameter derived from the CEST approach. For this study, patients with Parkinson’s disease, progressive supranuclear palsy and multiple system atrophy as well as healthy volunteers were examined. Region-of-interest analysis was performed in the substantia nigra and red nucleus area. As the results, the CEST parameters were significantly different for each of the neurodegenerative diseases and healthy volunteers. CEST imaging might have the ability to obtain more detailed information concerning neurodegenerative disease.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords